520A J-Pharma Co.,Ltd.ジェイファーマTSE Growth / Pharmaceuticals
0 posts
J-Pharma Co.,Ltd. (520A) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
J-Pharma Co.,Ltd. (520A) Stock Price History
J-Pharma Co.,Ltd. closed at ¥317 on Nov 20, 2026, −18.1% over 1 month.
If you had invested ¥100,000 1 month ago, it would be worth ¥81,912 today (−18.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −18.1%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥317 | −8 | −2.46% |
| Nov 19 (Thu) | ¥325 | −11 | −3.27% |
| Nov 18 (Wed) | ¥336 | +1 | +0.30% |
| Nov 17 (Tue) | ¥335 | −18 | −5.10% |
| Nov 16 (Mon) | ¥353 | −4 | −1.12% |
| Nov 13 (Fri) | ¥357 | −7 | −1.92% |
| Nov 12 (Thu) | ¥364 | +4 | +1.11% |
| Nov 11 (Wed) | ¥360 | +7 | +1.98% |
| Nov 10 (Tue) | ¥353 | +14 | +4.13% |
| Nov 9 (Mon) | ¥339 | +7 | +2.11% |
If you had invested ¥100,000 3 months ago, it would be worth ¥112,811 today (+12.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved +12.8%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥317 | −8 | −2.46% |
| Nov 19 (Thu) | ¥325 | −11 | −3.27% |
| Nov 18 (Wed) | ¥336 | +1 | +0.30% |
| Nov 17 (Tue) | ¥335 | −18 | −5.10% |
| Nov 16 (Mon) | ¥353 | −4 | −1.12% |
| Nov 13 (Fri) | ¥357 | −7 | −1.92% |
| Nov 12 (Thu) | ¥364 | +4 | +1.11% |
| Nov 11 (Wed) | ¥360 | +7 | +1.98% |
| Nov 10 (Tue) | ¥353 | +14 | +4.13% |
| Nov 9 (Mon) | ¥339 | +7 | +2.11% |
If you had invested ¥100,000 6 months ago, it would be worth ¥65,496 today (−34.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −34.5%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥317 | −21.3% |
| Oct 2026 | ¥403 | +0.2% |
| Sep 2026 | ¥402 | +27.2% |
| Aug 2026 | ¥316 | +17.5% |
| Jul 2026 | ¥269 | −11.8% |
| Jun 2026 | ¥305 | −42.0% |
| May 2026 | ¥526 | −5.1% |
If you had invested ¥100,000 1 year ago, it would be worth ¥45,286 today (−54.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +5.0%, while this stock moved −54.7%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥317 | −21.3% |
| Oct 2026 | ¥403 | +0.2% |
| Sep 2026 | ¥402 | +27.2% |
| Aug 2026 | ¥316 | +17.5% |
| Jul 2026 | ¥269 | −11.8% |
| Jun 2026 | ¥305 | −42.0% |
| May 2026 | ¥526 | −5.1% |
| Apr 2026 | ¥554 | −24.0% |
| Mar 2026 | ¥729 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Mar 2026). Please check the latest prices before trading.
J-Pharma Co.,Ltd. (520A) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of J-Pharma Co.,Ltd. (520A)
Business overview
The company is a venture pursuing drug discovery targeting SLC transporters. Aiming at the global market, it carries out clinical development with the goal of obtaining approval from major regulators such as the US FDA. It works with CROs and research institutions in the US and Europe and is developing treatments in areas including biliary tract cancer and multiple sclerosis.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 2.06x | Above the sector median of 1.86x (No. 43 from the lowest) |
|---|---|---|
| ROE | -102.85% | No. 51 in the sector (highest first); median 4.17% |
| Market cap | ¥5.7 bn | No. 59 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| High since 3/25 | ¥738 | 3/27 |
|---|---|---|
| Low since 3/25 | ¥261 | 7/30 |
| Current position | 11.7% | Where the low is 0% and the high is 100% (close on 11/20: ¥317) |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 3 times | Latest: 10/26 (No. 39) |
|---|---|---|
| Top 50 losers | 2 times | Latest: 10/29 (No. 27) |
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/11 15:302027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結)
- 11/11 15:30営業外費用(為替差損)の計上に関するお知らせ
- 10/30 15:30AAMED「難病・希少疾病治療グローバル研究開発支援事業」に係る補助金の交付決定および補助事業開始のお知らせ
- 10/05 12:00AMED「難病・希少疾病治療グローバル研究開発支援事業」採択に関するお知らせ
- 09/25 08:00JPH034に関する、欧州バイオテック企業との非拘束的なライセンス契約骨子案(Non-Binding Term Sheet)締結のお知らせ
Filings from the past 12 months (5).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the J-Pharma Co.,Ltd. board
More Japanese stocks in English
- Nihon Yamamura Glass Co.,Ltd.5210
- Nippon Electric Glass Co.,Ltd.5214
- KURAMOTO CO.,LTD.5216
- OHARA INC.5218
- iFreeETF FANG+GOLD521A
- COEL Inc.522A
- Sumitomo Osaka Cement Co.,Ltd.5232
- TAIHEIYO CEMENT CORPORATION5233
- NOZAWA CORPORATION5237
- SEIWA HOLDINGS Co.,Ltd.523A
- monoAI technology Co.,Ltd.5240
- EYEZ,INC.5242